Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 30, 2026
Chevron (CVX) Q1 2026 Earnings Preview: Facing a -55.6% EPS Decline

Chevron (CVX) Q1 2026 Earnings Preview: Facing a -55.6% EPS Decline

Key Takeaways

  • Analysts forecast Q1 2026 EPS (earnings per share) at $0.97, a 55.6% decline from $2.18 in Q1 2025, amid softer commodity prices.
  • Consensus revenue expected at $52.7 billion, reflecting ongoing demand but pressured margins.
  • Chevron guides Q1 upstream earnings boost of $1.6-2.2 billion from higher prices versus Q4 2025, offset by $2.7-3.7 billion in timing effects.
  • Net oil-equivalent production outlook at 3.8-3.9 MMBOED (million barrels of oil equivalent per day), impacted by downtime.
  • Chevron has beaten EPS estimates in the last four quarters, averaging 4% surprises.
  • Q4 2025 adjusted EPS of $1.52 topped estimates, with strong cash flow of $10.8 billion.

Why Chevron's Q1 Earnings Matter Now

Chevron's (CVX) Q1 2026 earnings, set for release on May 1, provide key insights into how the company is managing volatile energy markets. As an integrated supermajor, CVX's performance mirrors broader trends in global oil demand, refining pressures, and production efficiency, all against a backdrop of geopolitical risks and fluctuating prices. The strong Q4 results—with record production and $10.8 billion in cash flow—raise the bar, but announced challenges like derivative timing losses and legal reserves demand close attention. From what I see, updates on Permian Basin expansion, capital allocation, and returns to shareholders will be pivotal in defining CVX's position in the evolving energy sector.

Q1 Earnings Expectations

Wall Street's consensus calls for Q1 EPS of $0.97 on $52.7 billion in revenue, based on 19 analysts covering the quarter ended March 31, 2026. This represents a sharp year-over-year decline from $2.18 EPS, largely due to lower realized prices even as demand holds steady. In its April 9 guidance, Chevron noted upstream earnings gains of $1.6-2.2 billion from higher oil and gas prices compared to Q4 2025, but these are offset by $2.7-3.7 billion in after-tax timing effects, mainly from mark-to-market derivative losses and LIFO inventory accounting.

Worldwide net production is guided at 3.8-3.9 MMBOED, affected by downtime at Tengizchevroil and curtailments in the Middle East. Downstream faces a $350-400 million after-tax legal charge. Historically, CVX has outperformed: Q4 2025 adjusted EPS of $1.52 beat estimates by 5.6%, and Q3 by 8.4%, with the last four quarters averaging 4% positive surprises. Post-earnings stock moves have been modest, typically 2-5% gains on beats. I also checked CVX against peers using Tickeron’s AI Screener, which highlighted its resilience in production metrics.

Market Reaction and Investor Sentiment

Sentiment ahead of earnings is cautiously optimistic, buoyed by CVX's recent beat history. Shares are trading around $185, up modestly year-to-date thanks to production increases and buybacks. The April 9 pre-announcement drew a mixed reaction—upstream strengths balanced by costs—resulting in flat trading. Key risks include refining margin squeezes and oil price volatility, with implied volatility pointing to a 4-5% post-earnings move. Bulls are focused on full-year EPS consensus of $12.28, up 68% year-over-year, while bears point to macroeconomic pressures. One thing that stands out to me is how CVX has managed these swings effectively so far.

Tools I Use: Tickeron’s AI Screener

In my research process, Tickeron’s AI Screener stands out as a powerful tool for discovering stocks and ETFs. It leverages AI to scan thousands of assets using filters for technical patterns, fundamentals, trends, volatility, and signals—far more efficiently than manual methods. For energy names like CVX, I use it to identify breakout candidates or compare industry peers on metrics like production growth. It's become a staple in my workflow for spotting opportunities amid market noise.

Looking Ahead: Key Factors to Watch

I'm watching Chevron's refreshed full-year guidance closely, particularly on production goals and capital spending. The company targets 7-10% output growth excluding divestitures, driven by ramps in the Permian Basin and Guyana.

Commodity price sensitivity will be crucial: stronger Brent or Henry Hub levels could boost results, as noted in recent guidance. Refining margins remain a focus, given downstream exposure to crack spreads. Shareholder returns—via dividends and buybacks—highlight cash flow strength after Q4's $10.8 billion. Other catalysts include regulatory progress on ventures like Hess integration elements and ESG initiatives. Broader influences encompass OPEC+ policies, U.S. LNG exports, and renewables investments. In my view, disciplined cost management amid inflation will underscore operational strength.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: CVX

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for CVX turns positive, indicating new upward trend

CVX saw its Momentum Indicator move above the 0 level on August 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CVX just turned positive on August 11, 2026. Looking at past instances where CVX's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for CVX crossed bullishly above the 50-day moving average on July 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVX advanced for three days, in of 381 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 360 cases where CVX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 28, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.120) is normal, around the industry mean (1.932). P/E Ratio (19.756) is within average values for comparable stocks, (16.808). Projected Growth (PEG Ratio) (0.793) is also within normal values, averaging (1.314). Dividend Yield (0.034) settles around the average of (0.037) among similar stocks. P/S Ratio (1.945) is also within normal values, averaging (3.587).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 123.86B. The market cap for tickers in the group ranges from 39.76K to 678.92B. XOM holds the highest valuation in this group at 678.92B. The lowest valued company is PGAS at 39.76K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 20%. PBR experienced the highest price growth at 7%, while SLNG experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 53
Price Growth Rating: 43
SMR Rating: 64
Profit Risk Rating: 27
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
CVX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which explores and refines oil and natural gas

Industry IntegratedOil

Profile
Details
Industry
Integrated Oil
Address
6001 Bollinger Canyon Road
Phone
+1 925 842-1000
Employees
45600
Web
https://www.chevron.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.